Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Olanzapine 10mg tablets
040201060AAACAC
|
Olanzapine | Olanzapine | Central Nervous System | 154,216 |
|
Olanzapine 5mg tablets
040201060AAAAAA
|
Olanzapine | Olanzapine | Central Nervous System | 134,689 |
|
Olanzapine 2.5mg tablets
040201060AAADAD
|
Olanzapine | Olanzapine | Central Nervous System | 95,386 |
|
Olanzapine 20mg tablets
040201060AAAQAQ
|
Olanzapine | Olanzapine | Central Nervous System | 78,987 |
|
Olanzapine 15mg tablets
040201060AAALAL
|
Olanzapine | Olanzapine | Central Nervous System | 64,302 |
|
Olanzapine 7.5mg tablets
040201060AAABAB
|
Olanzapine | Olanzapine | Central Nervous System | 45,252 |
|
Olanzapine 5mg orodispersible tablets sugar free
040201060AAASAS
|
Olanzapine | Olanzapine | Central Nervous System | 7,583 |
|
Olanzapine 10mg orodispersible tablets sugar free
040201060AAATAT
|
Olanzapine | Olanzapine | Central Nervous System | 6,717 |
|
Olanzapine 20mg orodispersible tablets sugar free
040201060AAAVAV
|
Olanzapine | Olanzapine | Central Nervous System | 5,243 |
|
Olanzapine 5mg orodispersible tablets
040201060AAAWAW
|
Olanzapine | Olanzapine | Central Nervous System | 4,792 |
|
Olanzapine 10mg orodispersible tablets
040201060AAAXAX
|
Olanzapine | Olanzapine | Central Nervous System | 4,773 |
|
Olanzapine 20mg orodispersible tablets
040201060AAAZAZ
|
Olanzapine | Olanzapine | Central Nervous System | 3,126 |
|
Olanzapine 15mg orodispersible tablets sugar free
040201060AAAUAU
|
Olanzapine | Olanzapine | Central Nervous System | 3,081 |
|
Olanzapine 15mg orodispersible tablets
040201060AAAYAY
|
Olanzapine | Olanzapine | Central Nervous System | 1,445 |
|
Olanzapine 10mg oral lyophilisates sugar free
040201060AAAFAF
|
Olanzapine | Olanzapine | Central Nervous System | 721 |
|
Zyprexa 10mg tablets
040201060BBACAC
|
Zyprexa | Olanzapine | Central Nervous System | 721 |
|
Olanzapine 5mg oral lyophilisates sugar free
040201060AAAEAE
|
Olanzapine | Olanzapine | Central Nervous System | 696 |
|
Zyprexa 5mg tablets
040201060BBAAAA
|
Zyprexa | Olanzapine | Central Nervous System | 607 |
|
Zyprexa 2.5mg tablets
040201060BBADAD
|
Zyprexa | Olanzapine | Central Nervous System | 570 |
|
Zyprexa 10mg Velotabs
040201060BBAFAF
|
Zyprexa | Olanzapine | Central Nervous System | 306 |
|
Olanzapine 2.5mg/5ml oral suspension
040201060AABABA
|
Olanzapine | Olanzapine | Central Nervous System | 303 |
|
Zyprexa 5mg Velotabs
040201060BBAEAE
|
Zyprexa | Olanzapine | Central Nervous System | 288 |
|
Zyprexa 20mg Velotabs
040201060BBAJAP
|
Zyprexa | Olanzapine | Central Nervous System | 255 |
|
Zyprexa 20mg tablets
040201060BBAKAQ
|
Zyprexa | Olanzapine | Central Nervous System | 231 |
|
Olanzapine 20mg oral lyophilisates sugar free
040201060AAAPAP
|
Olanzapine | Olanzapine | Central Nervous System | 214 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.